Monsenso A/S

Equities

MONSO

DK0061277977

IT Services & Consulting

Market Closed - Nasdaq Copenhagen 05:57:10 2024-04-26 am EDT 5-day change 1st Jan Change
0.448 DKK +1.82% Intraday chart for Monsenso A/S +8.74% +55.02%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Monsenso A/S Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Monsenso A/S Provides Earnings Guidance for the Year 2023 CI
Monsenso A/S Provides Earnings Guidance for the Year 2024 CI
Monsenso to Deploy Patient Data Collection Platform to Unnamed Pharma Group MT
Monsenso A/S Signs New Agreement with Pharmaceutical for Real-World Data Project in Denmark CI
Monsenso A/S Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Monsenso A/S Signs Major New Agreement with A European Capital CI
Monsenso A/S Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Monsenso A/S Provides Earnings Guidance for the Full Year 2023 CI
European Community-Based Intervention Project Will Use Monsenso's Platform to Prevent Mental Illness CI
Monsenso A/S Participates in New, Large Innovation Project CI
Monsenso A/S Provides Revenue Guidance for the Full Year of 2022 CI
Monsenso A/S Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Monsenso A/S Announces Board Changes CI
Monsenso A/S Provides Earnings Guidance for the Year 2022 CI
Monsenso A/S Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Monsenso Signs an Agreement with Awakn Life Sciences CI
Monsenso Moves into a New Disorder Area with a New Project Covering Multiple Sclerosis CI
Monsenso A/S Revises Financial Guidance for the Year 2021 CI
Monsenso A/S Reports Earnings Results for the First Half of 2021 CI
10,223,984 Shares of Monsenso A/S are subject to a Lock-Up Agreement Ending on 3-JUN-2021. CI
Monsenso A/S Announces Board Changes CI
Monsenso Expands in the Middle East with New Million-Kroner Agreement with Global Pharmaceutical Company CI
Monsenso Signs New Agreement to Support Global Pharmaceutical Across Nine European Countries CI
Monsenso Partners with A Pan-European Consortium in the Go Green Routes Research Project CI
Chart Monsenso A/S
More charts
MONSENSO A/S is a Denmark-based medical software developer. The Company’s provides SaaS, cloud-based solution that connects people with mental disorders and their relatives or caregivers with their clinician (therapist or physician) for the purpose of increased data collection, collaboration and communication. MONSENSO A/S develops possibilities for health prevention, early intervention, and psychological disorders treatments.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. MONSO Stock
  4. News Monsenso A/S
  5. Monsenso to Deploy Patient Data Collection Platform to Unnamed Pharma Group